M, S., A, P., Z, M., S, B., B, C., L, C., . . . C, B. (2026). TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength. Nature communications, 17(1), 568. https://doi.org/10.1038/s41467-025-67263-w
Chicago Style (17th ed.) CitationM, Spiga, et al. "TIGIT Disruption Rescues the Antitumor Activity of Low Avidity TCR-engineered T Cells by Increasing TCR Signal Strength." Nature Communications 17, no. 1 (2026): 568. https://doi.org/10.1038/s41467-025-67263-w.
MLA (9th ed.) CitationM, Spiga, et al. "TIGIT Disruption Rescues the Antitumor Activity of Low Avidity TCR-engineered T Cells by Increasing TCR Signal Strength." Nature Communications, vol. 17, no. 1, 2026, p. 568, https://doi.org/10.1038/s41467-025-67263-w.